Concepedia

Publication | Closed Access

Clinical activity of vofatamab (V), an FGFR3 selective antibody in combination with pembrolizumab (P) in metastatic urothelial carcinoma (mUC), updated interim analysis of FIERCE-22

DOI

13

Citations

0

References

2019

Year

Arlene O. Siefker‐Radtke, Krzysztof Tupikowski, Zoran Andrić, Arash Rezazadeh Kalebasty, Giuseppe Curigliano, Daniel A. Vaena, Florian D. Vogl, Graeme Currie, Steve Abella, William Kevin Kelly
Annals of Oncology

No additional data available for this publication yet. Check back later!